Masoumeh Pourmohsen - Department of Midwifery, School of Nursing and Midwifery, Rasht Branch, Islamic Azad University, Rasht, Iran
Mandana Khoshravesh - Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

The HPV vaccine can reduce the risk of cervical cancer and improve the quality of life. HPV vaccination has been severely reduced by the COVID-۱۹ epidemic. The present study aimed to review the effect of epidemics on reducing HPV vaccine intake. Barriers to vaccination were assessed in three groups: individual, structural, logistical, and social. Individual barriers included fear of Covid-۱۹ exposure, lack of awareness, and anxiety. Structural and logistical barriers included the unavailability of services due to COVID-۱۹, interruption of school vaccinations, lack of personal protective equipment, and delays in diagnosis and treatment. Social and economic barriers included transportation delays, travel restrictions, social distance, anti-vaccine campaigns, high vaccine costs, global vaccine supply shortages, recession, and extreme poverty. Conclusion: Considering that HPV vaccination is a strategy to prevent cervical cancer, and since Covid-۱۹ has made it difficult to access the HPV vaccine, adopt health strategies and policies, including public education and information, vaccination Based on the school, it is essential to provide a single dose of the HPV vaccine until the problems with access to and delivery of the vaccine are resolved.

HPV Vaccine, COVID-۱۹ Epidemic, Cervical Cancer